Literature DB >> 7347560

Cefoxitin disposition during peritoneal dialysis.

W L Greaves, J H Kreeft, R I Ogilvie, G K Richards.   

Abstract

The pharmacokinetic disposition of 2 g of cefoxitin administered intravenously over 30 min was determined in six patients undergoing continuous ambulatory peritoneal dialysis for chronic renal failure. During the 6-h dialysate dwell time after the drug infusion, the mean apparent volume of distribution for cefoxitin was 0.267 liter/kg (range, 0.201 to 0.325 liter/kg), and the mean elimination t1/2 from plasma was 7.8 h (range, 5.5 to 13.1 h). The peritoneal clearance, averaging 1.51 ml/min (range, 0.58 to 2.35 ml/min), was only 7.4% of the mean plasmas clearance of cefoxitin. Cefoxitin clearance was reduced in patients with renal failure and was not increased by peritoneal dialysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7347560      PMCID: PMC181403          DOI: 10.1128/AAC.19.2.253

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Effects on renal function of treatment with cefoxitin alone or in combination with furosemide.

Authors:  B Trollfors; R Norrby; K Kristianson; N J Nilsson
Journal:  Scand J Infect Dis Suppl       Date:  1978

2.  Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency.

Authors:  G Humbert; J P Fillastre; A Leroy; M Godin; C Van Winzum
Journal:  Rev Infect Dis       Date:  1979 Jan-Feb

3.  Continuous ambulatory peritoneal dialysis in Canada.

Authors:  D G Oreopoulos
Journal:  Can Med Assoc J       Date:  1979-01-06       Impact factor: 8.262

4.  Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients.

Authors:  J P Fillastre; A Leroy; M Godin; G Oksenhendler; G Humbert
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

5.  Pharmacokinetics of cefoxitin in patients undergoing hemodialysis.

Authors:  M J Garcia; A Dominguez-Gil; J M Tabernero; A Bondia Román
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-08

Review 6.  Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.

Authors:  V T Andriole
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

7.  Peritonitis during continuous ambulatory peritoneal dialysis.

Authors:  J Rubin; W A Rogers; H M Taylor; E D Everett; B F Prowant; L V Fruto; K D Nolph
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

8.  Continuous ambulatory peritoneal dialysis.

Authors:  R P Popovich; J W Moncrief; K D Nolph; A J Ghods; Z J Twardowski; W K Pyle
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

  8 in total
  3 in total

Review 1.  Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors:  T W Paton; W R Cornish; M A Manuel; B G Hardy
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

Review 2.  Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review.

Authors:  R Janknegt; C H Koks
Journal:  Pharm Weekbl Sci       Date:  1984-12-14

3.  Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.

Authors:  A Arvidsson; G Alván; A Tranaeus; A S Malmborg
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.